• 1
    Rosenberg, B., Van Camp, L. and Krigas, T.: Inhibition of Cell Division in Escherichia Coli by Electrolysis Products from a Platinum Electrode. Nature, 205: 698699, 1965.
  • 2
    Rybak, L. P.: Cis-platinum Associated Hearing Loss. J. Laryngol. Otol., 95: 745747, 1981.
  • 3
    Ostrow, S., Egorin, M. J., Hahn, D., et al.: Cis-dichlorodiammine Platinum and Adriamycin Therapy for Advanced Gynecological and Genitourinary Neoplasms. Cancer, 46: 17151721, 1980.
  • 4
    Hall, J., Diasio, R. and Goplerud, D. R.: Cis-platinum in Gynecologic Cancer. III. Toxicity. Am. J. Obstet. Gynecol., 141: 309312, 1981.
  • 5
    McHaney, V. A., Thibadeau, G., Hayes, F. A., et al.: Auditory Function of Children Receiving Cis-platinum Chemotherapy. Proc. Am. Assoc. Cancer Res. and ASCO Abstracts, 22: 401, 1981.
  • 6
    Baum, E. S., Gaynon, P., Greenberg, L., et al.: Phase II Trial of Cisplatin in Refractory Childhood Cancer: Children's Cancer Study Group Report. Cancer Treat. Rep., 65: 815822, 1981.
  • 7
    Aguilar-Markulis, N. V., Beckley, S., Priore, R., et al.: Auditory Effects of Long-Term Cis-dichlorodiammineplatinum II. Therapy in Genitourinary Cancer Patients. J. Surg. Oncol., 16: 111123, 1981.
  • 8
    Reddel, R. R., Kefford, R. F., Grant, J. M., et al.: Ototoxicity in Patients Receiving Cisplatin: Importance of Dose and Method of Administration. Cancer Treat. Rep., 66: 1923, 1982.
  • 9
    Fleischman, R. W., Stadnicki, S. W., Ethier, M. F., et al.: Ototoxicity of Cis-dichlorodiammineplatinum (II) in the Guinea Pig. Toxicol. Appl. Pharmacol., 33: 320332, 1975.
  • 10
    Stadnicki, S. W., Fleischman, R. W., Schaeppi, U., et al.: Cis-dichlorodiammineplatinum (II) (NSC-119875): Hearing Loss and Other Toxic Effects in Rhesus Monkeys. Cancer Treat. Rep., 59: 467480, 1975.
  • 11
    Komune, S., Shinichiro, A. and Snow, J. B., Jr.: Pathophysiology of the Ototoxicity of Cis-diamminedichloroplatinum. Otolaryngol. Head Neck Surg., 89: 275282, 1981.
  • 12
    Scott, E. A., Babin, R. W., Ryu, J. A., et al.: Cis-diamminedichloroplatinum (II) Ototoxicity in the Guinea Pig. Otolaryngol. Head Neck Surg., 89: 638645, 1981.
  • 13
    Nakai, Y., Komishi, K. C., Chang, K., et al.: Ototoxicity of the Anticancer Drug Cis-platinum. An Experimental Study. Acta Otolaryngol., 93: 227232, 1982.
  • 14
    Wright, C. G. and Schaefer, S. D.: Inner-Ear Histopathology in Patients Treated with Cis-platinum. LARYNGOSCOPE, 92: 14081413, (Dec.) 1982.
  • 15
    Sando, I.: The Anatomical Interrelationships of the Cochlear Nerve Fibers. Acta Otolaryngol., 59: 417436, 1965.
  • 16
    Schuknecht, H. F.: Pathology of the Ear. Harvard University Press, Cambridge, MA, pp. 331333, 1974.
  • 17
    Engström, H. and Kohonen, A.: Cochlear Damage from Ototoxic Antibiotics. Acta Otolaryngol., 59: 171178, 1965.
  • 18
    Schuknecht, H. F.: Pathology of the Ear. Harvard University Press, Cambridge, MA, p. 276, 1974.
  • 19
    Kedar, A., Cohen, M. E. and Freeman, A. L.: Peripheral Neuropathy as a Complication of Cis-dichlorodiammineplatinum (II) Treatment. A Case Report. Cancer Treat. Rep., 62: 819821, 1978.
  • 20
    Von Hoff, D. D., Schilsky, R., Reichert, C. M., et al.: Toxic Effects of Cis-dichlorodiammineplatinum (II) in Man. Cancer Treat. Rep., 63: 15271531, 1979.
  • 21
    Von Hoff, D. D., Reichert, C. M., Cuneo, R., et al.: Demyelination of Peripheral Nerves Associated with Cis-diamminedichloroplatinum (II) (DDP) Therapy. Proc. Am. Assoc. Cancer Res. and ASCO Abstracts, 20: 91, 1979.